| CAS NO: | 167747-20-8 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 生物活性 | Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the FglycoproteinofRSV[1][2]. | ||||||||
| IC50& Target | EC50: 0.49 μg/mL (RSV Type A in microneutralization assay), 0.95 μg/mL (RSV Type A in fusion inhibition assay)[2] | ||||||||
| 体外研究 (In Vitro) | Felvizumab (RSHZ19) (2 h or 4 h) 抑制 RSV A 型，微量中和试验中 EC50为 0.49 ± 0.37 μg/mL，融合抑制试验中 EC50为 0.95 ± 0.13 μg/mL[2]。 | ||||||||
| 体内研究 (In Vivo) | Felvizumab (RSHZ19) (0.625-5.0 mg/kg; intramuscular injection; once) 在 RSV 感染大鼠模型中对 A 和 B 亚型 RSV 有效[2]。
| ||||||||
| CAS 号 | 167747-20-8 | ||||||||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com